IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Valeant Pharmaceuticals

Q2 2018 vs Q3 2019

Comparing institutional holders between quarters

Quarters

Q3 2019Q2 2018Q1 2018Q4 2017Q3 2017
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Syntal Capital Partners, LLC
NEW
Shares9,500
Change+9,500
Value$380
Filed 2019-11-14
Cullinan Associates Inc
CLOSED
Shares0 from 46,500
Change-46,500 (-100%)
Value$0 (-$1.1K)
Filed 2019-10-01
Baxter Bros Inc
CLOSED
Shares0 from 15,900
Change-15,900 (-100%)
Value$0 (-$370)
Filed 2019-10-21
Sonora Investment Management, LLC
CLOSED
Shares0 from 360
Change-360 (-100%)
Value$0 (-$8)
Filed 2019-10-15
Status
Syntal Capital Partners, LLC
NEW9,500—+9,500——$380—2019-11-14
Cullinan Associates Inc
CLOSED046,500-46,500-100%$1.1K$0-$1.1K2019-10-01
Baxter Bros Inc
CLOSED015,900-15,900-100%$370$0-$3702019-10-21
Sonora Investment Management, LLC
CLOSED0360-360-100%$8$0-$82019-10-15
Showing 4 of 4 institutions